Tamblyn, Robyn

Profile

Dr. Robyn Tamblyn is a Professor of Medicine, a James McGill Chair, and a Medical Scientist at the McGill University Health Centre. She is Scientific Director of the McGill Clinical and Health Informatics Research Group. She was appointed Scientific Director of the CIHR Institute of Health Services and Policy Research in 2011 and served in this position until her term ended in December 2018. In 2005 Dr Tamblyn received the CHSRF KT award for research in improving medication use and in 2006 she received the ACFAS Bombardier award for innovation in the development of a drug management system. In 2014, she received the John P. Hubbard Award for outstanding achievement in the assessment of professional competency in health care and medical education and she was appointed to the Order of Canada. In 2015 she received the Outstanding Achievement Award in the evaluation of clinical competence for sustained excellence in Canadian health care and research from the Medical Council of Canada. Dr Tamblyn was selected as the 2018 Justice Emmett Hall Laureate in recognition of her outstanding contributions to the health ideals extoled by Justice Hall and she was named the recipient of the 2018 Peggy Leatt Award in acknowledgement of her work in improving outcomes in Canada’s health care system. Recently, in 2019, she was elected as a Fellow to the Royal Society of Canada and she was appointed Director of the Division of Clinical Epidemiology at the McGill University Health Centre.

Outputs

Title	Category	Date	Authors
MOvIT Phase II: Feasibility of a monitoring intervention for older wheelchair users using MOvIT computerized calls	Scientific Excellence - Advancing Knowledge	2013-06-01	Claudine Auger, Robyn Tamblyn, Bill Miller, Jeff Jutai
Feasibility of Monitoring Mobility Outcomes for Wheelchair Users Aged Above 50 Years with Computerized Calls	Scientific Excellence - Advancing Knowledge	2012-10-01	Claudine Auger, Robyn Tamblyn, Bill Miller, Jeff Jutai
Conception d'une intervention de suivi systématique informatisée après l'attribution d'une aide à la mobilité: l'interface MOvIT	Scientific Excellence - Advancing Knowledge	2012-03-01	Claudine Auger, Robyn Tamblyn, Bill Miller, Jeff Jutai
The MOvIT project phase I: Designing a mobility device monitoring intervention with end-users and healthcare providers - Thematic Session: End-user Participation in the Development of Assistive Device Assessments and Outcome Measures	Scientific Excellence - Advancing Knowledge	2011-08-01	Claudine Auger, Robyn Tamblyn, Bill Miller, Jeff Jutai
Age and gender effect on the feasibility and acceptability of interactive voice response system calls for adverse drug event detection	Scientific Excellence - Advancing Knowledge	2011-06-01	Claudine Auger, Robyn Tamblyn, Oake N, Forster AJ
Patient, drug and physician characteristics of enrolled and non-enrolled adults for a computerized drug monitoring intervention	Scientific Excellence - Advancing Knowledge	2011-05-01	Claudine Auger, Robyn Tamblyn, Eguale T, Forster A
Automatiser le suivi après l’attribution des aides techniques : est-ce applicable au contexte de la réadaptation au Québec?	Scientific Excellence - Advancing Knowledge	2011-05-01	Claudine Auger, Robyn Tamblyn, Bill Miller, Jeff Jutai
Perceived usability of a computerized monitoring intervention for mobility device outcomes	Scientific Excellence - Advancing Knowledge	2014-04-01	Claudine Auger, Bill Miller, Jeff Jutai, Robyn Tamblyn
Is It Feasible To Monitor Mobility Outcomes For Older Wheelchair Users with Computerized Calls?	Scientific Excellence - Advancing Knowledge	2013-04-01	Claudine Auger, Bill Miller, Jeff Jutai, Robyn Tamblyn
Development and feasibility of an automated call monitoring intervention for older wheelchair users: the MOvIT project	Scientific Excellence - Advancing Knowledge	2014-04-01	Claudine Auger, Bill Miller, Jeff Jutai, Robyn Tamblyn
Usability of a computerized drug monitoring programme to detect adverse drug events and non-compliance in outpatient ambulatory care	Scientific Excellence - Advancing Knowledge	2013-04-01	Claudine Auger, Forster AJ, Oake N, Robyn Tamblyn
Effectiveness of a computerized drug-monitoring program to detect and prevent adverse drug events and medication non-adherence in outpatient ambulatory care: study protocol of a randomised controlled trial	Scientific Excellence - Advancing Knowledge	2015-01-01	Forster AJ, Erlanger TE, Jennings A, Claudine Auger, Buckeridge D, Van Walraven C, Robyn Tamblyn

Topic:
Specify:

Tamblyn, Robyn

From AGE-WELL Forum

Tamblyn, Robyn

Profile

Outputs